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Background: The superiority of tenotomy vs. tenodesis for surgery on lesions of the long head of the biceps
brachii tendon is still under debate. Indeed, high-quality evidence is lacking, mainly because of methodological
problems, such as retrospective design, population sample size or lack of patient randomization.
Methods/Design: The study will be a two-center, double-blind, randomized, controlled trial to compare patients
treated with biceps tenotomy or tenodesis for lesions of the long head of the biceps brachii tendon over a 2-year
follow-up period. The study participants will be 128 adults with biceps brachii tendinopathy and supraspinatus
tendon tears. The primary end point will be the postoperative difference in the Constant-Murley score (CMS)
between the 2 groups at the two-year follow-up. A comparison of the mean improvement with standard age- and
gender-related CMS will be performed. The secondary end point will be evaluation of the postoperative general
health of patients, as evaluated with Short Form 36 (SF-36) scores. The number and severity of complications
associated with use of the different surgical techniques will be assessed.
Discussion: This study will be the first randomized and appropriately powered clinical trial to directly compare
tenotomy and biceps tenodesis. The results of this study will help to establish clinical practice guidelines for
patients suffering from lesions of the long head of the biceps brachii tendon, providing important information to
patients and health care providers about the possible complications, outcome predictors and effectiveness of the
targeted interventions.
Trial Registration: Current Controlled Trials ISRCTN38839558
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Lesions of the long head of the biceps brachii tendon
(LHBT) are common [1,2], and when not adequately
treated, they may be responsible for persistent pain, as
well as functional impairment of the shoulder [3]. LHBT
lesions can be isolated [4] but are more frequently asso-
ciated with more complex disorders, such as shoulder
instability or supraspinatus tendon tears [5-7]. The deci-
sion about whether to proceed with conservative [8-12]
or surgical management of LHBT lesions might depend
on the associated shoulder disorders and the duration of
the symptoms [13].* Correspondence: gasparini@unicz.it
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reproduction in any medium, provided the orThe two most common procedures for LHBT lesions
are biceps tenotomy and biceps tenodesis [14]. Cur-
rently, there is no consensus regarding the most effective
surgical procedure because of the inconsistent results
and the limitations of the published studies [15,16].
Some authors have claimed that tenotomy is superior
and reported satisfactory results in most patients treated
with this technique [17-19]. Tenotomy has the advan-
tages of easier execution and, when performed alone, the
requirement of fewer restrictions during the postopera-
tive period with an earlier return to activity [15]. Other
authors reported similarly good results in most patients
treated with tenodesis of the LHB [20-23]. This tech-
nique seems to be able to prevent some of the most
common complications associated with tenotomy, such
as cramping of the brachial biceps muscle and retraction
of the biceps tendon [18,24]. The latter complication,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in 3-70% of patients undergoing tenotomy of the LHBT
and results in a cosmetic deformity [17,20]. Further pos-
sible complications related to the intervention repre-
sented by tenotomy include decreases in the strength of
flexion and supination of the arm and forearm, respect-
ively [11,25]. However, these findings are not consistent
with the results reported by others [16,24,26].
Most of the studies that compare the results of LHB
tenodesis and tenotomy are limited by methodological
deficiencies, such as retrospective design, low statistical
power or lack of patient randomization [14]. To the best
of our knowledge, there are no double-blind randomized
controlled trials on this topic. The purpose of this
double-blind randomized trial is to compare the effect-
iveness of tenodesis and tenotomy in the treatment of
LHBT lesions.
Methods/Design
This will be a two-center, double-blind, randomized,
prospective study of all consecutive patients to be trea-
ted for LHBT lesions with biceps tenotomy or biceps
tenodesis, including a 2-year follow-up period.
This study will require 12 months for patient enroll-
ment and an additional 2 years for the completion of
follow-up over a total of 3 years.
Aims and hypothesis
This study will seek to compare the efficacy of biceps
tenotomy and biceps tenodesis in the treatment of
LHBT lesions. The primary end point will be the post-
operative differences in Constant-Murley scores (CMS)
between the 2 groups at the two-year follow-up. The
secondary end point will be evaluation of the general
health of patients in both groups as evaluated by Short
Form 36 (SF-36) scores. The number and severity of
complications associated with the investigational surgical
techniques will be assessed. The null hypothesis is that
there will be no difference in the mean CMS between
the tenotomy and tenodesis groups.
Inclusion and exclusion criteria
A screening interview will be conducted to ensure that
the referred patients meet the inclusion/exclusion cri-
teria prior to performing study-specific tests. A thorough
physical examination and an MRI of the shoulder will be
performed for identification and characterization of the
pathology. The diagnosis will be verified by arthroscopy.
Male or female patients, aged 40 years or older, with
LHBT lesions (tenosynovitis, subluxation, dislocation or
partial rupture of the tendon) associated with grade I or
II full-thickness supraspinatus tendon tears [27] will
meet the criteria for enrollment. If any of the following
criteria apply, patients will be excluded: (1) previoussurgery of the affected shoulder, (2) insufficient compre-
hension of the Italian language to understand the trial
features, (3) mental handicap, (4) a lack of willingness to
return for all scheduled follow-up visits, (5) participation
in another study, (6) any previous upper extremity
neurological disorder or diagnosis based upon physical
examination, (7) complaint of pain in both shoulders, (8)
a life expectancy of less than 2 years, (9) an ongoing in-
surance trial, lawsuit, or pending legal action for shoul-
der disease.
Patients who do not meet all of the inclusion criteria
and patients who meet any of the exclusion criteria will
automatically be excluded from the study. Informed con-
sent will be obtained from each patient.
The number and source of patients
Patients will be recruited from the outpatient clinic. The
goal is to assess 128 participants for the study. We per-
formed a priori power analysis to determine the sample
size required to achieve the pre-specified power level
(1 - β), significance level α, and the population effect size
for the CMS between the two treatment groups to be
assessed. In a previous study, the CMS was normally dis-
tributed within some subject groups [28]; therefore, we
will use an unpaired t-test with an associated medium
effect size equal to 0.5. Under these conditions, we will
need to study 64 subjects for each group to be able to
reject the null hypothesis that the population means of
the groups are equal with a probability (power) of 0.8
and that the Type I error probability is equal to 0.05.
Considering the same significance and power level, this
sample size will allow us to detect an effect size that is
equal to 0.35 for the null hypothesis that the population
means of CMS scores before and after treatment are
equal. Because of the possibility that participants could
drop out of the protocol, a total of 150 patients will be
recruited for the trial. G*Power software (Institut fur
Experimentelle Psychologie, Heinrich Heine Universitat,
Dusseldorf, Germany) was used for the power analyses.
Randomization
After the participants have gone through the screening
process and are determined to meet the enrollment cri-
teria, they will be randomized to the treatment groups
(i.e., biceps tenotomy or biceps tenodesis). The patients
will be randomly allocated to the groups using specific
software (Filemaker Pro 12, Santa Clara, CA, USA) with
an allocation ratio of 1:1; they will be unaware of which
surgical treatment they will receive. Patients will be fully
informed that they have a 50% chance of receiving LHB
tenotomy and that there will be no opportunity for
cross-over treatments.
An independent secretary will organize treatment allo-
cation by distributing sealed numbered envelopes to the
Galasso et al. BMC Musculoskeletal Disorders 2012, 13:205 Page 3 of 7
http://www.biomedcentral.com/1471-2474/13/205nurse manager in the operation theatre. A nurse will
open the envelope only when a preoperative diagnostic
evaluation has documented the LHBT lesion and supras-
pinatus tendon tear.
Imaging
Preoperative radiological examination will include
anterior-posterior (AP) and outlet X-ray and a 1.5-T
non-arthrographic MRI of the shoulder (MagnetomW
Symphony-Maestro-Class, Siemens AG, Erlangen, Germany).
Indeed, non-contrast MRI has been reported to be 98%
sensitive and 89.5% specific for biceps tendon pathology
[29]. Imaging scans will include a fast spin-echo inter-
mediate-weighted axial sequence, a fast spin-echo coro-
nal oblique intermediate-weighted sequence, and coronal
oblique and sagittal oblique fast spin-echo T2-weighted
acquisitions with fat suppression. A full-thickness tear
will be defined as a high T2 signal extending through
the depth of the supraspinatus tendon [30].
Reports will be generated by two musculoskeletal radi-
ologists who will be blinded to the clinical characteristics
of the patients, and their evaluation will be repeated on
two separate days. Cohen’s kappa coefficient for the
inter-observer and intra-observer reliability of scoring
will be calculated. A consensus decision on the presence
of supraspinatus tendon tear and LHBT lesion (i.e., teno-
synovitis, subluxation, dislocation or partial rupture) will
be reached in a final common readout.
Intervention
The investigator performing the surgical intervention
will be blinded to the patient’s baseline and follow-up
clinical measurements. The surgeon will know which of
the two techniques will be employed for each patient
during the surgical procedure. One experienced shoulder
surgeon (RC) will perform all operations.
Both procedures will be performed in the lateral de-
cubitus position. The same number of skin incisions will
be required for the arthroscopic portals to repair the
supraspinatus tear and the LHB tenotomy or tenodesis.
A routine glenohumeral diagnostic arthroscopy will be
performed through a standard posterior arthroscopic
portal; lateral and rotator interval anterior portals will be
used to repair the supraspinatus tendon tear with a sin-
gle row technique after biceps treatment. TwinfixTM Ti
5.5 mm suture anchor with three #2 UltrabaridTM
sutures (Smith & Nephew Inc, Memphis, TN, USA) will
be used to repair the supraspinatus tendon.
Biceps Tenotomy
Tenotomies will be performed through the anterior gle-
nohumeral portal. A blunt probe will be used to pull
the extra-articular portion of the biceps into the gle-
nohumeral joint to allow for visual inspection of themacroscopic structural changes [31]. The biceps tendon
will then be released from its insertion on the superior
glenoid labrum using arthroscopic electrocautery.
Biceps Tenodesis
A biceptorTM tenodesis system (Smith & Nephew Inc,
Memphis, TN, USA) will be used during the procedure.
A spinal needle will be inserted at the anterior-lateral
edge of the acromion into the shoulder joint and
through the biceps. A monofilament suture will be intro-
duced through the needle and the biceps tendon. Then,
the long head of the biceps tendon will be cut at its in-
sertion point through the rotator interval portal under
the glenoid labrum. Both arms of the suture will exit the
anterior portal. The biceps tendon will be mobilized out
of the bicipital groove, and the desired position for reat-
taching the tendon will be located. A 2.4-mm guide wire
will be drilled perpendicularly to the humeral shaft in
the bicipital groove. A reamer appropriate to the screw
diameter will be used to drill a 25-30-mm deep hole for
definitive tendon attachment.
A tendon fork will be placed after tension release of
the tendon, and the tendon will be inserted into the pre-
pared hole up to the far cortex. The tendon will subse-
quently be pinned in place and a biosure peek-optimaW
(Smith & Nephew Inc, Memphis, TN, USA) interference
screw will be inserted over this pin. The excess tendon
will be trimmed.
Postoperative rehabilitation
The operated shoulder will be immobilized for 3 weeks
using a sling with an abduction pillow. Pendulum exer-
cises will be allowed, starting from the first postopera-
tive day. After the immobilization period, passive and
assisted exercises in forward flexion and external rota-
tion will be initiated. Strengthening exercises will be
restricted until 6 weeks after the surgical procedure.
Three months after the operation, patients will be
allowed to engage in light sports activity. Heavy manual
work and overhead motion will be allowed after 6
months.
Baseline and follow-up measurements
The baseline measurements and 1, 6, and 24-month fol-
low-up outcomes will be evaluated by two trained
attending physicians (MD and FF) blinded to the
patient’s treatment assignment. Demographic data, such
as age, gender, dominant arm, activity level (1 = seden-
tary, 2 = light manual work, 3 = heavy manual work),
concomitant injuries, surgical side, disease onset (0 =
acute, 1 = insidious), symptom duration, and prior failed
conservative therapies, will be collected at the beginning
of the study.
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baseline and at the follow-up examination: Speed’s test
[32], Yergason’s test [33], the palm-up test [34], the ac-
tive compression test [35], Neer’s sign [36], Jobe’s test
[37], and the lift-off test [38].
Physical examination will include bilateral measure-
ment of the active range of motion of the shoulder,
elbow flexion and extension and forearm pronosupina-
tion with a goniometer. Shoulder motions will include
forward flexion, abduction, external rotation and internal
rotation at 0° of abduction. The latter measurements
will be carried out with the patient in a sitting position
to prevent hyperlordosis. Scapular rotation will be res-
tricted during abduction and forward flexion by the
examiner’s hand.
CMS and SF-36 scores will be measured preoperatively
and at follow-up. The CMS was introduced to determine
the functional outcome after treatment for a shoulder
injury [39,40]. This score (0–100) is divided into four
subscales, including pain (15 points maximum), daily liv-
ing activities (20 points maximum), range of motion (40
points maximum), and strength (25 points maximum).
The higher the CMS score, the better the shoulder’s con-
dition. The postoperative difference in the CMS between
the groups will be evaluated at the two-year follow-up.
Comparison of these outcomes with standard age- and
gender-related CMS will be performed. As previously
described, patients will be considered a treatment suc-
cess if their CMS is at least 80% of the standard age-
and gender-related value at the study’s endpoint [27,41].
The baseline and follow-up isometric muscle strength
will be evaluated with the 500 N Mecmesin Myometer
(Mecmesin Co, Nottingham, UK) as previously indicated
for shoulder [42,43] and elbow [44] strength measure-
ments. External shoulder rotation will be tested with the
shoulder in a neutral position and the elbow in 90° of
flexion. The strap of the myometer will be applied to the
distal forearm of the patient. When measuring shoulder
strength during external rotation with the arm at the
side, the subject will be asked to externally rotate only
the forearm with the elbow kept at the side to prevent
compensation from motion of the torso or extension-
abduction of the humerus. Abduction shoulder strength
will be tested with the patient in the standing position
and the arm in 90° of abduction in the scapular plane
with the elbow extended and the forearm pronated, and
resistance will be applied to the wrist. If 90° of abduction
cannot be achieved, abduction strength will automatic-
ally be considered zero. To prevent leaning toward the
contralateral side and the additional use of the trunk
muscles, stabilization of the torso will be achieved by
direct contact of the contralateral shoulder and trunk
with a wall. Scapular rotation will be restricted by the
examiner’s hand. Forearm supination will be tested withthe elbow in 90° flexion, maximal pronation and 0° pro-
nation/supination. Stabilization straps will be secured
and foot markers noted during all testing to ensure a
standardized and reproducible protocol. Three submaxi-
mal effort trials will be performed in each axis to ac-
quaint the patient with the testing conditions. Three
maximal effort trials will be performed in each axis and
the recorded values will be averaged to measure the
strengths. A 5-minute rest period will be allowed be-
tween each testing period.
The normal contralateral upper extremity will be used
as a matched control in the evaluation of the postopera-
tive biceps strength measurement without adjusting the
results for handedness because no significant differences
have been observed between the dominant and nondo-
minant side of healthy volunteers [25]. Thus, the
achieved average elbow flexion strength of the affected
arm will be compared with the healthy opposite side of
the patient, and the percentage will be graded between 0
and 20 points, as previously described [45]. In this re-
gard, 20 points will be given to a performance of 91%
and above; 16 points, between 90% and 81%; 12 points,
between 80% and 71%; 8 points, between 70% and 61%;
4 points, between 60% and 51%; and 0 points to a per-
formance below 50%.
The SF-36 is a validated, multi-purpose, short-form
health survey with 36 questions, which combine eight
health domains into a physical (PCS) and mental com-
ponent scale (MCS) [46]. The PCS combines the health
domains of physical functioning (PF), role limitations
due to physical health (RP), bodily pain (BP), and general
health perceptions (GH). The MCS combines the health
domains of vitality, energy, or fatigue (VT), social func-
tioning (SF), role limitations due to emotional problems
(RE), and general mental health (MH). SF-36 scores
range from zero to 100 points with lower scores indicat-
ing poorer function [47,48]. The postoperative difference
in the SF-36 scores between the 2 groups will be evalu-
ated at the two-year follow-up.
At the final follow-up, the patients and the blinded in-
vestigator will be asked to guess which treatment they
believe the patient received to assess blinding and
randomization.
Complications and shoulder pain medication usage
The investigators who will be blinded to the surgical
treatment will be responsible for identifying the compli-
cations related to the surgical procedure (e.g., the failure
of tendon fixation, pain at the level of the bicipital
groove, nerve injury, infection or skin scarring at the
surgical site, cosmetic deformity) that might affect each
subject throughout the study and follow-up period.
Patients will be asked to provide baseline documentation
on their medication usage for shoulder pain to be
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up visits. The generic name, dosage, and frequency of
these medications will be recorded. The presence of
cramping will be noted following a verbal report from
the patient.
Statistical analysis
The mean, standard deviation and range will be reported
for the continuous variables (symptom duration, CMS
and SF-36 scores), whereas counts will be used to de-
scribe the categorical variables (gender, dominant arm,
surgical side, concomitant injuries, disease onset, prior
conservative therapies, shoulder tests, surgical tech-
nique, cramping, surgical complications, medication
usage). Discrete variables will also be analyzed (activity
level, LHBT condition). A determination of whether the
CMS and SF-36 absolute and percent changes from
baseline can reasonably be modeled using Gaussian the-
ory will be performed by examining normal probability
plots.
Mean CMS and SF-36 scores will be compared be-
tween and within treatment groups at each follow-up
using repeated measure analysis of variance (ANOVA)
methods on the appropriate scale. The chi-squared test
will be used for the comparison of binary measures. If a
parametric analysis is feasible, t-tests will be used for the
comparison of continuous measures. If the Gaussian
model is not appropriate, non-parametric comparison
methods will be used on medians, as well as means. In
particular, the Mann–Whitney U-test will be used to as-
sess the difference in score distribution between the
groups, whereas the Wilcoxon test will be used to com-
pare the scores within the group. The percent of drop-
outs over time will also be compared in each treatment
group. Complications will be compared by treatment
group using exact chi-squared methods. Confidence
intervals will be reported for the incidence of complica-
tions. Age-weighted univariate and multiple stepwise lin-
ear and logistic regression analyses will be used to
evaluate the relationships between explanatory variables
and outcomes with continuous and categorical distribu-
tions, respectively. Only explanatory and confounding
variables that show a trend toward an association with
the outcome of interest (e.g., p < 0.10) in the univariate
analysis will be inserted into these models. In the mul-
tiple linear regression analysis, total adjusted R2 for the
model and changes in R2 for the independent contribu-
tion of single predictors will be calculated to assess the
total variance in the outcome variable accounted for by
the whole model and single explanatory variables, re-
spectively. In the case of collinearity between the ex-
planatory variables, only the best-fitting models (e.g.,
those including the collinear explanatory variable
accounting for the most relevant variation in thevariance of the outcome) will be adopted. A P value of
less than 0.05 will be considered significant. The SPSS
(SPSS Statistics 17.0, Inc., Chicago, IL, USA) software
program for Windows will be used for the database and
statistical analysis.
Ethics
The trial will be conducted in Fermo (Italy) and Catanzaro
(Italy) according to the principles of the Helsinki dec-
laration. Participants will receive information about the
study protocol before providing written consent for in-
clusion in the study. Ethics approval for this study
has been received from the Ethics Committee of the
“Azienda Ospedaliera Mater Domini”, Catanzaro, Italy,
(ref. number 2011–57), which acts as the central ethics
committee for this trial. Approval has been obtained
from the local ethics committee of the other participa-
ting center. With the patient’s permission, an informa-
tional letter describing the patient’s participation will be
sent to his or her general practitioner. No special in-
surance will be provided for the patients because the
protocol treatments are common surgical procedures
routinely used in the centers involved in the study.
All participant surgeons will be trained with regard to
the study procedures at the beginning of the study.
Discussion
To the best of our knowledge, this will be the first
double-blind randomized controlled trial to compare
clinical scores of tenodesis and tenotomy in the treat-
ment of LHBT lesions. There are a few studies in the lit-
erature that directly compare the results of these
techniques, and most of them reveal no differences be-
tween treatments [11,24-26,49,50]. Boileau et al. retro-
spectively evaluated 68 patients with irreparable rotator
cuff tears treated with isolated arthroscopic biceps tenot-
omy or tenodesis and reported similar outcomes after
both procedures [24]. Osbahr et al. retrospectively stud-
ied 160 patients with chronic refractive bicipital pain,
treating half of the patients with tenotomy and the other
half with tenodesis [49]. They found no significant differ-
ence between the two treatment methods in terms of
cosmetic deformity, muscle spasm or anterior shoulder
pain. Similarly, when twenty patients who underwent bi-
ceps tenotomy or tenodesis for chronic tenosynovitis
were compared retrospectively, no difference in the
functional or cosmetic results was observed [50].
Wittstein et al. showed no significant difference in
postoperative scores between the two techniques in a
cohort study of 35 patients [25]. The major limitations
of this study were a lack of randomization of partici-
pants receiving tenotomy or tenodesis and a limited
number of participants. In agreement with a retrospect-
ive study [11], the authors also found that tenotomy
Galasso et al. BMC Musculoskeletal Disorders 2012, 13:205 Page 6 of 7
http://www.biomedcentral.com/1471-2474/13/205decreased forearm supination compared with tenodesis.
These findings were not confirmed in other studies,
which reported no difference between these techniques
[16,24,26]. Shank et al. compared the forearm supination
and elbow flexion strength of the upper extremity and
found no significant difference between the tenotomy,
tenodesis, and control groups [26]. However, they did
not report the clinical scores after these surgeries [26].
Koh and colleagues demonstrated that neither clinical
scores nor total surgical times revealed significant differ-
ences between tenotomy and tenodesis [16]. Notably,
this study was not a randomized trial, and the study
group was underpowered for most of the outcomes.
Therefore, the authors acknowledge that their results
should be interpreted with care.
The need for appropriately powered, well-conducted,
randomized, controlled trials that compare the outcomes
of these procedures has recently been emphasized [15].
To improve studies investigating biceps tenotomy versus
tenodesis, the analysis of several variables, including pa-
tient demographics, concomitant injuries, CMS, surgical
complications, and specific clinical outcomes, such as
cramping or cosmetic deformity, has been recommended
[14]. The results of our trial will provide important in-
formation to patients and health care providers about
the effectiveness of these targeted interventions, possible
complications, and predictors of outcome.
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